News
The agreement covers integrating DBL-4penâ„¢, Diabeloop's self-learning algorithm for MDI therapy, with Novo Nordisk's connected and reusable insulin pens, NovoPen® 6 and NovoPen Echo® Plus.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results